Meeting on Thursday, May 7, 2026, the Board of Directors of New Body Line approved the financial statements for the 2025 fiscal year.
While the company had posted a staggering loss of over 4.1 million dinars in 2024, the individual pre-tax result returned to positive territory in 2025, reaching 1 million dinars.
This performance is confirmed by the individual net result, which came in at 754 thousand dinars, after a deficit of 4.5 million dinars recorded the previous year.
Although the consolidated accounts technically remain in the red, the improvement is spectacular.
The Group’s share of net result stood at -62 thousand dinars in 2025. By comparison, this figure was -6.1 million dinars in 2024.
This massive reduction in losses suggests that restructuring or turnaround measures within the Group’s subsidiaries are beginning to bear fruit, now nearing breakeven.
Return of dividend and annual meeting
As a sign of confidence in the restored strength of the company’s cash position and its prospects, the Board of Directors has decided to propose the distribution of a dividend of 0.050 dinar per share.
The Ordinary General Meeting on June 29 will provide an opportunity for management to detail its strategy for maintaining this growth momentum in 2026.
